oral PRMT5 inh. for treating cancers

projected human dose of 15 mg QD w/ 6 HBD

SBDD from SAM cofactor

J. Med. Chem., Mar. 23, 2021

Merck & Co, Boston, MA

Structure of compound 72

The Merck protein arginine methyltransferase 5 (PRMT5) inhibitor (“compound 72”) is a SAM cofactor-mimetic with a novel 5,5-fused carbon-based bicyclic scaffold. PRMT5 is an actively pursued epigenetic target for…


get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: